Cosmos Financial Statements From 2010 to 2026

COSM Stock  USD 0.46  0.02  4.17%   
Cosmos Health's financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Cosmos Health's valuation are provided below:
Gross Profit
6.8 M
Profit Margin
(0.31)
Market Capitalization
16.6 M
Enterprise Value Revenue
0.6305
Revenue
59.8 M
There are over one hundred nineteen available fundamental signals for Cosmos Health, which can be analyzed over time and compared to other ratios. Self-guided Investors are advised to validate Cosmos Health's prevailing fundamentals against the trend between 2010 and 2026 to make sure the company can sustain itself down the road. As of the 2nd of February 2026, Market Cap is likely to grow to about 12.1 M. Also, Enterprise Value is likely to grow to about 23 M

Cosmos Health Total Revenue

35.97 Million

Check Cosmos Health financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Cosmos Health's main balance sheet or income statement drivers, such as Interest Expense of 1.6 M, Selling General Administrative of 14.2 M or Other Operating Expenses of 84.5 M, as well as many indicators such as Price To Sales Ratio of 0.22, Dividend Yield of 0.38 or PTB Ratio of 0.49. Cosmos financial statements analysis is a perfect complement when working with Cosmos Health Valuation or Volatility modules.
  
Build AI portfolio with Cosmos Stock
Check out the analysis of Cosmos Health Correlation against competitors.
To learn how to invest in Cosmos Stock, please use our How to Invest in Cosmos Health guide.

Cosmos Health Balance Sheet

Current ValueLast YearHistorical Average 10 Year Trend
Total Current Liabilities31.1 M29.6 M15.9 M
Slightly volatile
Accounts Payable13.5 M12.8 MM
Slightly volatile
Common Stock Shares Outstanding23.1 M22 M5.1 M
Slightly volatile
Non Current Liabilities Total4.9 M4.6 M4.5 M
Slightly volatile
Total Liabilities17.8 M34.2 M18.3 M
Slightly volatile
Common Stock41.4 K21.3 K49.3 K
Slightly volatile
Total Assets65.6 M62.5 M28 M
Slightly volatile
Short and Long Term Debt Total12.2 M13.6 M10.1 M
Slightly volatile
Other Current Liabilities5.8 M5.6 M1.8 M
Slightly volatile
Cash344.3 K362.4 K1.8 M
Pretty Stable
Cash And Short Term Investments367.4 K386.7 K1.8 M
Pretty Stable
Liabilities And Stockholders Equity65.6 M62.5 M27.4 M
Slightly volatile
Total Current Assets19.1 M29.3 M18.1 M
Slightly volatile
Short Term Debt9.2 M11.2 M7.7 M
Slightly volatile
Non Current Assets Total34.8 M33.2 M9.2 M
Slightly volatile
Non Currrent Assets Other5.9 M5.7 M1.8 M
Slightly volatile
Other Current Assets4.9 M5.6 M3.7 M
Slightly volatile
Property Plant And Equipment Net12.6 M12 M3.4 M
Slightly volatile
Property Plant Equipment2.3 M2.2 MM
Slightly volatile
Net Receivables14.5 M18.3 M9.7 M
Slightly volatile
Inventory3.2 MM2.3 M
Slightly volatile
Net Invested Capital30.5 M41 M20.2 M
Slightly volatile
Capital Stock25.9 K27.2 K37.9 K
Pretty Stable

Cosmos Health Income Statement

Current ValueLast YearHistorical Average 10 Year Trend
Interest Expense1.6 M1.2 M1.5 M
Slightly volatile
Selling General Administrative14.2 M13.5 M6.3 M
Slightly volatile
Other Operating Expenses84.5 M80.5 M35.2 M
Slightly volatile
Total Operating Expenses24 M22.8 M11.2 M
Slightly volatile
Selling And Marketing Expenses599.9 K408.2 K439.9 K
Very volatile
Total Revenue36 M62.6 M29 M
Slightly volatile
Gross Profit4.4 MM3.5 M
Slightly volatile
Cost Of Revenue31.6 M57.6 M25.6 M
Slightly volatile
Reconciled Depreciation1.5 M1.4 M381.8 K
Slightly volatile

Cosmos Health Cash Flow Statement

Current ValueLast YearHistorical Average 10 Year Trend
Total Cash From Financing Activities6.7 M5.8 M6.1 M
Slightly volatile
End Period Cash Flow344.3 K362.4 K1.8 M
Pretty Stable
Begin Period Cash Flow2.3 M4.4 M2.1 M
Slightly volatile
Depreciation1.5 M1.4 M374.8 K
Slightly volatile

Financial Ratios

Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio0.220.210.0791
Slightly volatile
Dividend Yield0.380.440.475
Slightly volatile
Days Sales Outstanding84.2495.8591.9518
Slightly volatile
Average Payables10.5 M10 MM
Slightly volatile
Stock Based Compensation To Revenue0.03220.03570.0457
Pretty Stable
Capex To Depreciation0.290.33.3088
Very volatile
Inventory Turnover8.8210.368.3568
Slightly volatile
Days Of Inventory On Hand46.8936.4872.4664
Slightly volatile
Payables Turnover3.834.044.0292
Slightly volatile
Sales General And Administrative To Revenue0.310.250.3479
Slightly volatile
Average Inventory2.4 M4.1 M2.3 M
Slightly volatile
Research And Ddevelopement To Revenue0.00780.00880.0096
Slightly volatile
Capex To Revenue0.00660.00690.0205
Pretty Stable
Cash Per Share0.0150.01581.8147
Very volatile
Days Payables Outstanding88.7893.45194
Slightly volatile
Intangibles To Total Assets0.130.14280.0354
Slightly volatile
Current Ratio0.940.891.1445
Pretty Stable
Receivables Turnover6.483.945.7026
Pretty Stable
Capex Per Share0.01870.01970.3089
Pretty Stable
Average Receivables17.8 M16.9 M9.7 M
Slightly volatile
Revenue Per Share2.432.5627.693
Pretty Stable
Interest Debt Per Share0.570.614.1455
Pretty Stable
Debt To Assets0.240.252.416
Slightly volatile
Graham Number43.4548.8853.3558
Slightly volatile
Operating Cycle118124163
Slightly volatile
Days Of Payables Outstanding88.7893.45194
Slightly volatile
Ebt Per Ebit1.141.2131
Slightly volatile
Quick Ratio0.860.741.0478
Very volatile
Net Income Per E B T0.70.950.7832
Slightly volatile
Cash Ratio0.01340.01410.272
Slightly volatile
Days Of Inventory Outstanding46.8936.4872.4664
Slightly volatile
Days Of Sales Outstanding84.2495.8591.9518
Slightly volatile
Free Cash Flow Operating Cash Flow Ratio0.90.951.0706
Pretty Stable
Fixed Asset Turnover5.726.02219
Slightly volatile
Debt Ratio0.240.252.416
Slightly volatile
Price Sales Ratio0.220.210.0791
Slightly volatile
Asset Turnover1.51.151.2979
Very volatile
Gross Profit Margin0.08650.09110.2161
Slightly volatile

Cosmos Health Valuation Data

Current ValueLast YearHistorical Average 10 Year Trend
Market Cap12.1 M11.5 M4.1 M
Slightly volatile

Cosmos Fundamental Market Drivers

Forward Price Earnings52.6316
Cash And Short Term Investments336.3 K

Cosmos Upcoming Events

11th of April 2024
Upcoming Quarterly Report
View
31st of December 2023
Next Fiscal Quarter End
View

About Cosmos Health Financial Statements

Cosmos Health investors utilize fundamental indicators, such as revenue or net income, to predict how Cosmos Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
Last ReportedProjected for Next Year
Current Deferred Revenue-145.9 K-138.6 K
Total Revenue62.6 M36 M
Cost Of Revenue57.6 M31.6 M
Stock Based Compensation To Revenue 0.04  0.03 
Sales General And Administrative To Revenue 0.25  0.31 
Research And Ddevelopement To Revenue 0.01  0.01 
Capex To Revenue 0.01  0.01 
Revenue Per Share 2.56  2.43 
Ebit Per Revenue(0.33)(0.31)

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Prophet is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Prophet
When determining whether Cosmos Health is a strong investment it is important to analyze Cosmos Health's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Cosmos Health's future performance. For an informed investment choice regarding Cosmos Stock, refer to the following important reports:
Check out the analysis of Cosmos Health Correlation against competitors.
To learn how to invest in Cosmos Stock, please use our How to Invest in Cosmos Health guide.
You can also try the Idea Optimizer module to use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio .
Will Health Care Providers & Services sector continue expanding? Could Cosmos diversify its offerings? Factors like these will boost the valuation of Cosmos Health. Projected growth potential of Cosmos fundamentally drives upward valuation adjustments. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Cosmos Health data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Earnings Share
(0.77)
Revenue Per Share
2.196
Quarterly Revenue Growth
0.379
Return On Assets
(0.13)
Return On Equity
(0.64)
Investors evaluate Cosmos Health using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating Cosmos Health's intrinsic value—the estimated true worth—helps identify when the stock trades at a discount or premium to fair value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. External factors like market trends, sector rotation, and investor psychology can cause Cosmos Health's market price to deviate significantly from intrinsic value.
It's important to distinguish between Cosmos Health's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Cosmos Health should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Conversely, Cosmos Health's market price signifies the transaction level at which participants voluntarily complete trades.